Personalized Medicine Potential of Cyclacel’s Innovative and Diverse Oncology Pipeline Highlighted at NCRI Cancer Conference

[at noodls] – BERKELEY HEIGHTS, N.J., Nov. 6, 2012 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced today multiple posters presented on the Company’s … more

View todays social media effects on CYCC

View the latest stocks trending across Twitter. Click to view dashboard